A case of "late-onset" idiopathic infantile hypercalcemia secondary to mutations in the CYP24A1 gene

Endocrine Practice

Volumn 20, Issue 5, 2014, Pages

  Wolf, Peter ^a   Müller Sacherer, Thomas ^a   Baumgartner Parzer, Sabina ^a   Winhofer, Yvonne ^a   Kroo, Judit ^b   Gessl, Alois ^a   Luger, Anton ^a   Krebs, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Division of Endocrinology and Metabolism Health Center of Regional Medical Insurance Company of Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; HYDROCHLOROTHIAZIDE; NUCLEOTIDE; PARATHYROID HORMONE; VITAMIN D;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM INTAKE; CALCIUM URINE LEVEL; CASE REPORT; CAUCASIAN; CYP24A1 GENE; DAIRY PRODUCT; ECHOGRAPHY; FISH; FOLLOW UP; GENE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; IDIOPATHIC DISEASE; IDIOPATHIC INFANTILE HYPERCALCEMIA; INFANT DISEASE; INFORMED CONSENT; LOW DRUG DOSE; MALE; MILK; NEPHROLITHIASIS; PARATHYROID HORMONE BLOOD LEVEL; RADIATION EXPOSURE; ULTRAVIOLET RADIATION; URINARY EXCRETION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; YOUNG ADULT;

EID: 84900433980     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP13479.CR     Document Type: Article

References (20)

1. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am JPhysiol Renal Physiol. 2005;289:F8-F28.
2. Prosser DE, Jones G. Enzymes involved in the activationand inactivation of vitamin D. Trends Biochem Sci. 2004;29:664-673.
3. Schlingmann KP, Kaufmann M, Weber S, et al.Mutations in CYP24A1 and idiopathic infantile hypercalcemia.N Engl J Med. 2011;365:410-421.
4. Jones G, Prosser DE, Kaufmann M. 25-HydroxyvitaminD-24-hydroxylase (CYP24A1): its important role in thedegradation of vitamin D. Arch Biochem Biophys. 2012;523:9-18.
5. Lightwood R, Stapleton T. Idiopathic hypercalcaemia ofinfants. Lancet. 1953;265:255-256.
6. Nesterova G, Malicdan MC, Yasuda K, et al. 1,25-(OH)2D-24 Hydroxylase (CYP24A1) deficiency as a causeof nephrolithiasis. Clin J Am Soc Nephrol. 2013;8:649-657.
7. St-Arnaud R, Arabian A, Travers R, et al. Deficientmineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitaminD and not to the absence of 24,25-dihydroxyvitaminD. Endocrinology. 2000;141: 2658-2666.
8. Masuda S, Byford V, Arabian A, et al. Altered pharmacokineticsof 1alpha,25-dihydroxyvitamin D3 and25-hydroxyvitamin D3 in the blood and tissues of the25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) nullmouse. Endocrinology. 2005;146:825-834.
9. Dauber A, Nguyen TT, Sochett E, et al. Genetic defect inCYP24A1, the vitamin D 24-hydroxylase gene, in a patientwith severe infantile hypercalcemia. J Clin EndocrinolMetab. 2012;97:E268-E274.
10. Martin N, Snodgrass G, Cohen R. Idiopathic infantilehypercalcaemia-a continuing enigma. Arch Dis Child.1984;59:605613.
11. Castanet M, Mallet E, Kottler ML. Lightwood syndromerevisited with a novel mutation in CYP24 and vitaminD supplement recommendations. J Pediatr. 2013;163:1208-1210.
12. Rodd C, Goodyer P. Hypercalcemia of the newborn: etiology,evaluation, and management. Pediatr Nephrol. 1999;13:542-547.
13. Huang J, Coman D, McTaggart SJ, Burke JR. Longtermfollow-up of patients with idiopathic infantile hypercalcaemia.Pediatr Nephrol. 2006;21:1676-1680.
14. Tebben PJ, Milliner DS, Horst RL, et al. Hypercalcemia,hypercalciuria, and elevated calcitriol concentrations withautosomal dominant transmission due to CYP24A1 mutations:effects of ketoconazole therapy. J Clin EndocrinolMetab. 2012;97:E423-E427.
15. Streeten E, Zarbalian K, Damcott C. CYP24A1Mutations in idiopathic infantile hypercalcemia. New EnglJ Med. 2011;365:1741-1742; author reply.
16. Dinour D, Beckerman P, Ganon L, Tordjman K,Eisenstein Z, Holtzman EJ. Loss-of-function mutationsof CYP24A1, the vitamin D 24-hydroxylase gene, causelong-standing hypercalciuric nephrolithiasis and nephrocalcinosis.J Urol. 2013;190:552-557.
17. Fencl F, Bláhová K, Schlingmann KP, Konrad M,Seeman T. Severe hypercalcemic crisis in an infant withidiopathic infantile hypercalcemia caused by mutation inCYP24A1 gene. Eur J Pediatr. 2013;172:45-49.
18. Meusburger E, Mündlein A, Zitt E, Obermayer-PietschB, Kotzot D, Lhotta K. Medullary nephrocalcinosis in anadult patient with idiopathic infantile hypercalcaemia and anovel CYP24A1 mutation. Clin Kidney J. 2013;6:211-215.
19. Skalova S, Cerna L, Bayer M, Kutilek S, Konrad M,Schlingmann KP. Kidney diseases intravenous pamidronatein the treatment of severe idiopathic infantile hypercalcemia.Iran J Kidney Dis. 2013;7:160-164.
20. Stechman MJ, Loh NY, Thakker RV. Genetics of hypercalciuricnephrolithiasis: renal stone disease. Ann N Y AcadSci. 2007;1116:461-484.